Mid-Term Evaluation of the Unicompartmental Knee Arthroplasty in Patients with BMI of 40 or Greater.


Journal

The journal of knee surgery
ISSN: 1938-2480
Titre abrégé: J Knee Surg
Pays: Germany
ID NLM: 101137599

Informations de publication

Date de publication:
Mar 2021
Historique:
pubmed: 11 9 2019
medline: 20 5 2021
entrez: 11 9 2019
Statut: ppublish

Résumé

Limited evidence is available on mid-term follow-up for patients with body mass index (BMI) ≥ 40 receiving a unicompartmental knee arthroplasty (UKA). The primary objective of this study was to investigate survival of the UKA in patients with BMI ≥ 40. Secondary objectives were to assess functional and patient reported outcome measures (PROMs). Survival analysis with endpoint revision of any component for any reason was conducted using Kaplan-Meier technique on 121 knees (103 patients) that underwent UKA with Oxford Phase 3 implant (Oxford Knee, Biomet, Swindon, United Kingdom) between September 2001 and March 2014 by seven surgeons. Survivorship differences were compared using Log Rank (Mantel-Cox) tests, and Cox Proportional Hazard Model was used to assess predictors of failure. Preoperative PROMs were compared at 2 and 5 years postoperatively using paired

Identifiants

pubmed: 31505699
doi: 10.1055/s-0039-1696735
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

427-433

Informations de copyright

Thieme. All rights reserved.

Déclaration de conflit d'intérêts

None declared.

Auteurs

Akshay Seth (A)

Division of Orthopaedic Surgey, The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada.

Johanna Dobransky (J)

Division of Orthopaedic Surgey, The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada.

Waleed Albishi (W)

Division of Orthopaedic Surgey, The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada.

Geoffrey F Dervin (GF)

Division of Orthopaedic Surgey, The Ottawa Hospital, General Campus, Ottawa, Ontario, Canada.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH